Alcea Therapeutics
NY - New YorkBiotechnology
Focus: Alcea Therapeutics is a newly founded (2024) biotechnology company specializing in monoclonal antibody development based in New York. Stage, funding status, and scale remain undisclosed.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Alcea Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Alcea Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Indole-3-carbinol
EndometriosisClinical Trials (1)
NCT07164183Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis
Phase 3Help build intelligence for Alcea Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.